Citations refer to the original publication, not to a Scieee localized version.
Luke, J. J., Ascierto, P. A., Khattak, M. A., Cruz Merino, L. D. L., Del Vecchio, M., Rutkowski, P., & Long, G. V. (2024). Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: final analysis of distant metastasis-free survival in the phase III KEYNOTE-716 study. Amer soc clinical oncology; Lippincott williams & wilkins. https://doi.org/10.1200/JCO.23.02355
Luke, Jason J., et al. Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: final analysis of distant metastasis-free survival in the phase III KEYNOTE-716 study. Amer soc clinical oncology; Lippincott williams & wilkins, 2024. https://doi.org/10.1200/JCO.23.02355.
Luke, Jason J., Paolo A. Ascierto, Muhammad A. Khattak, Luis de la Cruz Merino, Michele Del Vecchio, Piotr Rutkowski, and Georgina V. Long. Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: final analysis of distant metastasis-free survival in the phase III KEYNOTE-716 study. Amer soc clinical oncology; Lippincott williams & wilkins, 2024. https://doi.org/10.1200/JCO.23.02355.
Luke, J. J. et al. (2024) Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: final analysis of distant metastasis-free survival in the phase III KEYNOTE-716 study. Amer soc clinical oncology; Lippincott williams & wilkins. Available at: https://doi.org/10.1200/JCO.23.02355.
J. J. Luke et al., “Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: final analysis of distant metastasis-free survival in the phase III KEYNOTE-716 study,” Amer soc clinical oncology; Lippincott williams & wilkins, 2024, doi: 10.1200/JCO.23.02355.
@misc{luke2024pembrolizumab,
author = {Luke, Jason J. and Ascierto, Paolo A. and Khattak, Muhammad A. and Cruz Merino, Luis de la and Del Vecchio, Michele and Rutkowski, Piotr and Long, Georgina V.},
title = {Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: final analysis of distant metastasis-free survival in the phase III KEYNOTE-716 study},
year = {2024},
publisher = {Amer soc clinical oncology; Lippincott williams \& wilkins},
doi = {10.1200/JCO.23.02355},
url = {https://doi.org/10.1200/JCO.23.02355}
}
The source metadata has no journal, volume or pages. Add them from the original publication if your citation needs them.
